CoChat

De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock

Routsi, Christina, Gkoufa, Aikaterini, Arvaniti, Kostoula, Kokkoris, Stelios, Tourtoglou, Alexandros, Theodorou, Vassiliki, Vemvetsou, Anna, Kassianidis, Georgios, Amerikanou, Athena, Paramythiotou, Elisabeth, Potamianou, Efstathia, Ntorlis, Kyriakos, Kanavou, Angeliki, Nakos, Georgios, Hassou, Eleftheria, Antoniadou, Helen, Karaiskos, Ilias, Prekates, Athanasios, Armaganidis, Apostolos, Pnevmatikos, Ioannis, Kyprianou, Miltiades, Zakynthinos, Spyros, Poulakou, Garyfallia, Giamarellou, Helen · 2020 · Journal of Antimicrobial Chemotherapy
Cited by 46

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: De-escalation of empirical antimicrobial therapy, a key component of antibiotic stewardship, is considered difficult in ICUs with high rates of antimicrobial resistance. Objectives: To assess the feasibility and the impact of antimicrobial de-escalation in ICUs with high rates of antimicrobial resistance. Methods: Multicentre, prospective, observational study in septic patients with documented infections. Patients in whom de-escalation was applied were compared with patients without de-escalation by the use of a propensity score matching by SOFA score on the day of de-escalation initiation. Results: A total of 262 patients (mean age 62.2 ± 15.1 years) were included. Antibiotic-resistant pathogens comprised 62.9%, classified as MDR (12.5%), extensively drug-resistant (49%) and pandrug-resistant (1.2%). In 97 (37%) patients de-escalation was judged not feasible in view of the antibiotic susceptibility results. Of the remaining 165 patients, judged as patients with de-escalation possibility, de-escalation was applied in 60 (22.9%). These were matched to an equal number of patients without de-escalation. In this subset of 120 patients, de-escalation compared with no de-escalation was associated with lower all-cause 28 day mortality (13.3% versus 36.7%, OR 0.27, 95% CI 0.11–0.66, P = 0.006); ICU and hospital mortality were also lower. De-escalation was associated with a subsequent collateral decrease in the SOFA score. Cox multivariate regression analysis revealed de-escalation as a significant factor for 28 day survival (HR 0.31, 95% CI 0.14–0.70, P = 0.005). Conclusions: In ICUs with high levels of antimicrobial resistance, feasibility of antimicrobial de-escalation was limited because of the multi-resistant pathogens isolated. However, when de-escalation was feasible and applied, it was associated with lower mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jac/dkaa375

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 46

Metadata

Authors
Routsi, C., Gkoufa, A., Arvaniti, K., Kokkoris, S., Tourtoglou, A., Theodorou, V., Vemvetsou, A., Kassianidis, G., Amerikanou, A., Paramythiotou, E., Potamianou, E., Ntorlis, K., Kanavou, A., Nakos, G., Hassou, E., Antoniadou, H., Karaiskos, I., Prekates, A., Armaganidis, A., Pnevmatikos, I., Kyprianou, M., Zakynthinos, S., Poulakou, G., & Giamarellou, H.
Venue
Journal of Antimicrobial Chemotherapy
Published
2020-08-31
Volume
75
Issue
12
Pages
3665-3674
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W3082561061
Cited by
46
References
8
FWCI
3.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. https://app.cochat.ai/papers/10.1093/jac/dkaa375
The paper
Routsi, C., Gkoufa, A., Arvaniti, K., Kokkoris, S., Tourtoglou, A., Theodorou, V., Vemvetsou, A., Kassianidis, G., Amerikanou, A., Paramythiotou, E., Potamianou, E., Ntorlis, K., Kanavou, A., Nakos, G., Hassou, E., Antoniadou, H., Karaiskos, I., Prekates, A., Armaganidis, A., . . . Giamarellou, H. (2020). De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaa375

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.